Analysis of DNAtrix's Drug DNX-2401, 2023 to 2032: A Promising Candidate for Glioblastoma Multiforme (GBM) Treatment
January 30, 2024 05:01 ET
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "DNX-2401 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. The pharmaceutical industry...
TC-210 Drug and Market Report 2023-2032: Revolutionizing the Malignant Pleural Mesothelioma (MPM) Treatment Landscape
January 29, 2024 13:09 ET
|
Research and Markets
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "TC-210 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. The clinical landscape of...
Groundbreaking VE303 Therapeutic Candidate for Clostridium Difficile Infection (CDI) Sparks Transformation in Pharma Landscape: Detailed Analysis Reveals Potential Market Impact Though 2032
January 29, 2024 12:57 ET
|
Research and Markets
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "VE303 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. Cutting-Edge VE303 Drug Expected...
Market Overview of Centrexion Therapeutics' CNTX-4975 Drug, 2023-2032, Potentially Revolutionizing the Treatment Landscape for Osteoarthritis
January 29, 2024 12:41 ET
|
Research and Markets
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "CNTX-4975 Emerging Drug Insight and Market Forecast to 2032" report has been added to ResearchAndMarkets.com's offering. Emerging therapeutic...
Overview of Sorrento Therapeutics' RTX (MCP-101, resiniferatoxin) Drug Across the 7MM, 2023-2032
January 29, 2024 12:37 ET
|
Research and Markets
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "RTX Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. This reports delivers an...
TTP399 Drug Insights and Forecasts Across the 7MM, 2023-2032
January 29, 2024 12:31 ET
|
Research and Markets
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "TTP399 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. The research outlined in this...
XP-3924 Report 2023: Drug Development, Sales, and Market Forecast to 2032
January 29, 2024 12:20 ET
|
Research and Markets
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "XP-3924 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. The global healthcare...
Emerging IMCY-0098 Drug Insights and Market Forecasts to 2032: Type 1 Diabetes Mellitus Market Set for Expansion
January 29, 2024 12:19 ET
|
Research and Markets
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "IMCY-0098 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. This market forecast of the...
Emerging ONC201 Drug Set to Transform Glioblastoma Multiforme Treatment Landscape: Drug Insights and Market Forecasts to 2032
January 29, 2024 12:18 ET
|
Research and Markets
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "ONC201 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. This comprehensive report...
PF-06425090 (C. difficile Vaccine): Pharmaceutical Development and Market Forecast Insights to 2032
January 29, 2024 12:17 ET
|
Research and Markets
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "PF-06425090 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. This report casts light...